ANDA 210698, held by Dr Reddys. Succinylcholine Chloride.
As of Nov 16, 2026, ANDA 210698 (Succinylcholine Chloride), held by Dr Reddys, was first approved by FDA on Aug 2, 2019, with 3 approved supplements and 0 published complete response letters.
Indications & Usage Succinylcholine chloride is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 2, 2019 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Succinylcholine Chloride20MG/ML · injectable;injection | Succinylcholine Chloride | Rx |
| Sep 22, 2022 | Supplement 9Labeling · Standard review | Approved | None posted |
| Oct 25, 2021 | Supplement 7Labeling · Standard review | Approved | None posted |
| Feb 11, 2021 | Supplement 6Labeling · Standard review | Approved | None posted |
| Aug 2, 2019 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters